skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Mostrar Somente
Refinado por: Base de dados/Biblioteca: Academic Search Premier (EB_SDU_P3) remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Human Blood Serum Counteracts EGFR/HER2-Targeted Drug Lapatinib Impact on Squamous Carcinoma SK-BR-3 Cell Growth and Gene Expression
Human Blood Serum Counteracts EGFR/HER2-Targeted Drug Lapatinib Impact on Squamous Carcinoma SK-BR-3 Cell Growth and Gene Expression
Material Type:
Artigo 		Adicionar ao Meu Espaço

Human Blood Serum Counteracts EGFR/HER2-Targeted Drug Lapatinib Impact on Squamous Carcinoma SK-BR-3 Cell Growth and Gene Expression

Shaban, Nina ; Raevskiy, Mikhail ; Zakharova, Galina ; Shipunova, Victoria ; Deyev, Sergey ; Suntsova, Maria ; Sorokin, Maksim ; Buzdin, Anton ; Kamashev, Dmitri

Biochemistry (Moscow), 2024-03, Vol.89 (3), p.487-506 [Periódico revisado por pares]

Moscow: Pleiades Publishing

Texto completo disponível

Citações Citado por
2
First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial
First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial

Janjigian, Yelena Y ; Shitara, Kohei ; Moehler, Markus ; Garrido, Marcelo ; Salman, Pamela ; Shen, Lin ; Wyrwicz, Lucjan ; Yamaguchi, Kensei ; Skoczylas, Tomasz ; Campos Bragagnoli, Arinilda ; Liu, Tianshu ; Schenker, Michael ; Yanez, Patricio ; Tehfe, Mustapha ; Kowalyszyn, Ruben ; Karamouzis, Michalis V ; Bruges, Ricardo ; Zander, Thomas ; Pazo-Cid, Roberto ; Hitre, Erika ; Feeney, Kynan ; Cleary, James M ; Poulart, Valerie ; Cullen, Dana ; Lei, Ming ; Xiao, Hong ; Kondo, Kaoru ; Li, Mingshun ; Ajani, Jaffer A

The Lancet (British edition), 2021-07, Vol.398 (10294), p.27-40 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
3
The foundations of immune checkpoint blockade and the ipilimumab approval decennial
The foundations of immune checkpoint blockade and the ipilimumab approval decennial
Material Type:
Artigo 		Adicionar ao Meu Espaço

The foundations of immune checkpoint blockade and the ipilimumab approval decennial

Korman, Alan J ; Garrett-Thomson, Sarah C ; Lonberg, Nils

Nature reviews. Drug discovery, 2022-07, Vol.21 (7), p.509-528 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
4
Targeting cancer metabolism in the era of precision oncology
Targeting cancer metabolism in the era of precision oncology
Material Type:
Artigo 		Adicionar ao Meu Espaço

Targeting cancer metabolism in the era of precision oncology

Stine, Zachary E ; Schug, Zachary T ; Salvino, Joseph M ; Dang, Chi V

Nature reviews. Drug discovery, 2022-02, Vol.21 (2), p.141-162 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
5
First-line nivolumab plus ipilimumab in unresectable malignant pleural mesothelioma (CheckMate 743): a multicentre, randomised, open-label, phase 3 trial
First-line nivolumab plus ipilimumab in unresectable malignant pleural mesothelioma (CheckMate 743): a multicentre, randomised, open-label, phase 3 trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

First-line nivolumab plus ipilimumab in unresectable malignant pleural mesothelioma (CheckMate 743): a multicentre, randomised, open-label, phase 3 trial

Baas, Paul ; Scherpereel, Arnaud ; Nowak, Anna K ; Fujimoto, Nobukazu ; Peters, Solange ; Tsao, Anne S ; Mansfield, Aaron S ; Popat, Sanjay ; Jahan, Thierry ; Antonia, Scott ; Oulkhouir, Youssef ; Bautista, Yolanda ; Cornelissen, Robin ; Greillier, Laurent ; Grossi, Francesco ; Kowalski, Dariusz ; Rodríguez-Cid, Jerónimo ; Aanur, Praveen ; Oukessou, Abderrahim ; Baudelet, Christine ; Zalcman, Gérard

The Lancet (British edition), 2021-01, Vol.397 (10272), p.375-386 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
6
Gemtuzumab ozogamicin in acute myeloid leukemia
Gemtuzumab ozogamicin in acute myeloid leukemia
Material Type:
Artigo 		Adicionar ao Meu Espaço

Gemtuzumab ozogamicin in acute myeloid leukemia

Godwin, C D ; Gale, R P ; Walter, R B

Leukemia, 2017-09, Vol.31 (9), p.1855-1868 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
7
Pembrolizumab plus chemotherapy versus chemotherapy alone for first-line treatment of advanced oesophageal cancer (KEYNOTE-590): a randomised, placebo-controlled, phase 3 study
Pembrolizumab plus chemotherapy versus chemotherapy alone for first-line treatment of advanced oesophageal cancer (KEYNOTE-590): a randomised, placebo-controlled, phase 3 study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Pembrolizumab plus chemotherapy versus chemotherapy alone for first-line treatment of advanced oesophageal cancer (KEYNOTE-590): a randomised, placebo-controlled, phase 3 study

Sun, Jong-Mu ; Shen, Lin ; Shah, Manish A ; Enzinger, Peter ; Adenis, Antoine ; Doi, Toshihiko ; Kojima, Takashi ; Metges, Jean-Philippe ; Li, Zhigang ; Kim, Sung-Bae ; Cho, Byoung Chul ; Mansoor, Wasat ; Li, Shau-Hsuan ; Sunpaweravong, Patrapim ; Maqueda, Maria Alsina ; Goekkurt, Eray ; Hara, Hiroki ; Antunes, Luis ; Fountzilas, Christos ; Tsuji, Akihito ; Oliden, Victor Castro ; Liu, Qi ; Shah, Sukrut ; Bhagia, Pooja ; Kato, Ken

The Lancet (British edition), 2021-08, Vol.398 (10302), p.759-771 [Periódico revisado por pares]

London: Elsevier Ltd

Texto completo disponível

Citações Citado por
8
HER2-positive breast cancer
HER2-positive breast cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

HER2-positive breast cancer

Loibl, Sibylle, Prof ; Gianni, Luca, MD

The Lancet (British edition), 2017-06, Vol.389 (10087), p.2415-2429 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
9
Neoadjuvant nivolumab or nivolumab plus ipilimumab in operable non-small cell lung cancer: the phase 2 randomized NEOSTAR trial
Neoadjuvant nivolumab or nivolumab plus ipilimumab in operable non-small cell lung cancer: the phase 2 randomized NEOSTAR trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Neoadjuvant nivolumab or nivolumab plus ipilimumab in operable non-small cell lung cancer: the phase 2 randomized NEOSTAR trial

Cascone, Tina ; William, Jr, William N ; Weissferdt, Annikka ; Leung, Cheuk H ; Lin, Heather Y ; Pataer, Apar ; Godoy, Myrna C B ; Carter, Brett W ; Federico, Lorenzo ; Reuben, Alexandre ; Khan, Md Abdul Wadud ; Dejima, Hitoshi ; Francisco-Cruz, Alejandro ; Parra, Edwin R ; Solis, Luisa M ; Fujimoto, Junya ; Tran, Hai T ; Kalhor, Neda ; Fossella, Frank V ; Mott, Frank E ; Tsao, Anne S ; Blumenschein, Jr, George ; Le, Xiuning ; Zhang, Jianjun ; Skoulidis, Ferdinandos ; Kurie, Jonathan M ; Altan, Mehmet ; Lu, Charles ; Glisson, Bonnie S ; Byers, Lauren Averett ; Elamin, Yasir Y ; Mehran, Reza J ; Rice, David C ; Walsh, Garrett L ; Hofstetter, Wayne L ; Roth, Jack A ; Antonoff, Mara B ; Kadara, Humam ; Haymaker, Cara ; Bernatchez, Chantale ; Ajami, Nadim J ; Jenq, Robert R ; Sharma, Padmanee ; Allison, James P ; Futreal, Andrew ; Wargo, Jennifer A ; Wistuba, Ignacio I ; Swisher, Stephen G ; Lee, J Jack ; Gibbons, Don L ; Vaporciyan, Ara A ; Heymach, John V ; Sepesi, Boris

Nature medicine, 2021-03, Vol.27 (3), p.504-514 [Periódico revisado por pares]

United States: Nature Publishing Group

Texto completo disponível

Citações Citado por
10
Efficacy and safety of pembrolizumab in recurrent/metastatic head and neck squamous cell carcinoma: pooled analyses after long-term follow-up in KEYNOTE-012
Efficacy and safety of pembrolizumab in recurrent/metastatic head and neck squamous cell carcinoma: pooled analyses after long-term follow-up in KEYNOTE-012
Material Type:
Artigo 		Adicionar ao Meu Espaço

Efficacy and safety of pembrolizumab in recurrent/metastatic head and neck squamous cell carcinoma: pooled analyses after long-term follow-up in KEYNOTE-012

Mehra, Ranee ; Seiwert, Tanguy Y ; Gupta, Shilpa ; Weiss, Jared ; Gluck, Iris ; Eder, Joseph P ; Burtness, Barbara ; Tahara, Makoto ; Keam, Bhumsuk ; Kang, Hyunseok ; Muro, Kei ; Geva, Ravit ; Chung, Hyun Cheol ; Lin, Chia-Chi ; Aurora-Garg, Deepti ; Ray, Archana ; Pathiraja, Kumudu ; Cheng, Jonathan ; Chow, Laura Q M ; Haddad, Robert

British journal of cancer, 2018-07, Vol.119 (2), p.153-159 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Recursos Online (5.744)
  2. Revistas revisadas por pares (5.685)

Refinar Meus Resultados

Tipo de Recurso 

  1. Artigos  (5.748)
  2. magazinearticle  (11)
  3. Newsletter Articles  (2)
  4. Mais opções open sub menu

Assunto 

  1. Science & Technology  (5.200)
  2. Life Sciences & Biomedicine  (4.324)
  3. Humans  (4.246)
  4. Targeted Cancer Therapy  (3.313)
  5. Oncology  (3.046)
  6. Monoclonal Antibodies  (2.310)
  7. Cancer  (2.234)
  8. Tumors  (2.008)
  9. Patients  (2.006)
  10. Cancer Therapies  (1.888)
  11. Immunotherapy  (1.863)
  12. Female  (1.794)
  13. Chemotherapy  (1.584)
  14. Molecular Targeted Therapy  (1.521)
  15. Metastasis  (1.458)
  16. Care And Treatment  (1.368)
  17. Male  (1.355)
  18. Animals  (1.247)
  19. Health Aspects  (1.159)
  20. Metastases  (1.133)
  21. Mais opções open sub menu

Data de Publicação 

De até
Refinar
  1. Antes de2003  (11)
  2. 2003Até2007  (68)
  3. 2008Até2012  (425)
  4. 2013Até2018  (2.552)
  5. Após 2018  (2.706)
  6. Mais opções open sub menu

Idioma 

  1. Inglês  (5.759)
  2. Japonês  (953)
  3. Norueguês  (5)
  4. Russo  (3)
  5. Turco  (2)
  6. Português  (1)
  7. Chinês  (1)
  8. Francês  (1)
  9. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.